117 related articles for article (PubMed ID: 34999421)
1. Induced pluripotent stem cell line ICGi036-A generated by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia caused due to compound heterozygous p.Ser177Leu/p.Cys352Arg mutations in LDLR.
Zakharova IS; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Zubkova ES; Sleptcov AA; Nazarenko MS; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Stem Cell Res; 2022 Mar; 59():102653. PubMed ID: 34999421
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell line ICGi037-A, obtained by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia due to heterozygous p.Trp443Arg mutations in LDLR.
Zakharova IS; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Kalinin AP; Sleptcov AA; Nazarenko MS; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Stem Cell Res; 2022 Apr; 60():102703. PubMed ID: 35152179
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cell line ICGi038-A, obtained by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia due to compound heterozygous c.1246C > T/c.940 + 3_940 + 6del mutations in LDLR.
Zakharova IS; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Zubkova ES; Sleptcov AA; Nazarenko MS; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Stem Cell Res; 2022 Apr; 60():102702. PubMed ID: 35152178
[TBL] [Abstract][Full Text] [Related]
4. An integration-free iPSC line ZZUNEUi029-A derived from peripheral blood mononuclear cells of a patient with familial hypercholesterolemia carrying a mutation in LDLR gene.
Zhu K; Zhao J; Qin F; Chen X; Xu H; Li X; Tao H
Stem Cell Res; 2023 Sep; 71():103182. PubMed ID: 37586167
[TBL] [Abstract][Full Text] [Related]
5. iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.
Zakharova IS; Shevchenko AI; Arssan MA; Sleptcov AA; Nazarenko MS; Zarubin AA; Zheltysheva NV; Shevchenko VA; Tmoyan NA; Saaya SB; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255763
[TBL] [Abstract][Full Text] [Related]
6. Cohort Generation and Characterization of Patient-Specific Familial Hypercholesterolemia Induced Pluripotent Stem Cells.
Omer L; Hudson EA; Hudgins LC; Boyd NL
Stem Cells Dev; 2021 Jun; 30(12):632-640. PubMed ID: 34029164
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
8. Patient-Specific Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells as a Model to Study Autosomal Recessive Hypercholesterolemia.
Nikasa P; Tricot T; Mahdieh N; Baharvand H; Totonchi M; Hejazi MS; Verfaillie CM
Stem Cells Dev; 2021 Jul; 30(14):714-724. PubMed ID: 33938231
[TBL] [Abstract][Full Text] [Related]
9. JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia.
Cayo MA; Cai J; DeLaForest A; Noto FK; Nagaoka M; Clark BS; Collery RF; Si-Tayeb K; Duncan SA
Hepatology; 2012 Dec; 56(6):2163-71. PubMed ID: 22653811
[TBL] [Abstract][Full Text] [Related]
10. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3.
Dementyeva EV; Pavlova SV; Chernyavsky AM; Zakian SM
Stem Cell Res; 2021 May; 53():102344. PubMed ID: 33892289
[TBL] [Abstract][Full Text] [Related]
11. Function and Immunogenicity of Gene-corrected iPSC-derived Hepatocyte-Like Cells in Restoring Low Density Lipoprotein Uptake in Homozygous Familial Hypercholesterolemia.
Okada H; Nakanishi C; Yoshida S; Shimojima M; Yokawa J; Mori M; Tada H; Yoshimuta T; Hayashi K; Yamano T; Hanayama R; Yamagishi M; Kawashiri MA
Sci Rep; 2019 Mar; 9(1):4695. PubMed ID: 30886174
[TBL] [Abstract][Full Text] [Related]
12. Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.
Banerjee P; Chan KC; Tarabocchia M; Benito-Vicente A; Alves AC; Uribe KB; Bourbon M; Skiba PJ; Pordy R; Gipe DA; Gaudet D; Martin C
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2248-2260. PubMed ID: 31578082
[TBL] [Abstract][Full Text] [Related]
13. Generation of an induced pluripotent stem cell line, ICGi028-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.E510Q mutation in HADHA.
Dementyeva EV; Vyatkin YV; Chernyavsky AM; Zakian SM
Stem Cell Res; 2021 May; 53():102348. PubMed ID: 33887580
[TBL] [Abstract][Full Text] [Related]
14. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
15. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
Ustyantseva EI; Medvedev SP; Vetchinova AS; Illarioshkin SN; Leonov SV; Zakian SM
Stem Cell Res; 2020 Jan; 42():101675. PubMed ID: 31830646
[TBL] [Abstract][Full Text] [Related]
16. A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes.
Yang J; Wong LY; Tian XY; Wei R; Lai WH; Au KW; Luo Z; Ward C; Ho WI; Ibañez DP; Liu H; Bao X; Qin B; Huang Y; Esteban MA; Tse HF
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30272645
[TBL] [Abstract][Full Text] [Related]
17. A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene.
Li Z; Zhang X; Li X; Yang Y; Xin H; Yang X; Liu N; Gai Z; Liu Y
Stem Cell Res; 2021 May; 53():102313. PubMed ID: 34087978
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cell line, ICGi034-A, by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease associated with GBA mutation.
Grigor'eva EV; Drozdova ES; Sorogina DA; Malakhova AA; Pavlova SV; Vyatkin YV; Khabarova EA; Rzaev JA; Medvedev SP; Zakian SM
Stem Cell Res; 2022 Mar; 59():102651. PubMed ID: 35007918
[TBL] [Abstract][Full Text] [Related]
19. Establishment of pluripotent stem cell line induced by PATL2 heterozygous mutation in patients with oocyte maturation defect-4.
Xue N; Wang Y; Xu X; Jiang X; Li C; Wang J; Zhou P; Cao Y; Wei Z
Stem Cell Res; 2022 May; 61():102776. PubMed ID: 35397397
[TBL] [Abstract][Full Text] [Related]
20. Induced Pluripotent Stem Cell (iPSC) Lines from a Family with Resistant Epileptic Encephalopathy Caused by Compound Heterozygous Mutations in
Cattelani C; Battistella I; Di Leva F; Fioravanti G; Benedicenti F; Stanzial F; Schwienbacher C; Fanelli F; Pramstaller PP; Hicks AA; Conti L; Corti C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
